353 related articles for article (PubMed ID: 16627519)
21. Commentary: Empirical evidence of attrition bias in clinical trials.
Jüni P; Egger M
Int J Epidemiol; 2005 Feb; 34(1):87-8. PubMed ID: 15649954
[No Abstract] [Full Text] [Related]
22. [STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE].
Ernest P; Jandrain B; Scheen AJ
Rev Med Liege; 2015; 70(5-6):232-6. PubMed ID: 26285444
[TBL] [Abstract][Full Text] [Related]
23. Early participant attrition from clinical trials: role of trial design and logistics.
Siddiqi AE; Sikorskii A; Given CW; Given B
Clin Trials; 2008; 5(4):328-35. PubMed ID: 18697847
[TBL] [Abstract][Full Text] [Related]
24. Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).
Kane JM
J Clin Psychiatry; 2006 May; 67(5):831-2. PubMed ID: 16841634
[No Abstract] [Full Text] [Related]
25. Last-observation-carried-forward imputation method in clinical efficacy trials: review of 352 antidepressant studies.
Woolley SB; Cardoni AA; Goethe JW
Pharmacotherapy; 2009 Dec; 29(12):1408-16. PubMed ID: 19947800
[TBL] [Abstract][Full Text] [Related]
26. The performance of sample selection estimators to control for attrition bias.
Grasdal A
Health Econ; 2001 Jul; 10(5):385-98. PubMed ID: 11466801
[TBL] [Abstract][Full Text] [Related]
27. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
Schulz KF; Altman DG; Moher D;
Int J Surg; 2011; 9(8):672-7. PubMed ID: 22019563
[No Abstract] [Full Text] [Related]
28. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
Djulbegovic B; Cantor A; Clarke M
Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
[TBL] [Abstract][Full Text] [Related]
29. A statistic to avoid being misled by the "winners curse".
Tugwell P; Knottnerus JA
J Clin Epidemiol; 2018 Nov; 103():vi-viii. PubMed ID: 30293635
[No Abstract] [Full Text] [Related]
30. Credibility of claims of subgroup effects in randomised controlled trials: systematic review.
Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
BMJ; 2012 Mar; 344():e1553. PubMed ID: 22422832
[TBL] [Abstract][Full Text] [Related]
31. Putting the record straight: granisetron's efficacy as an antiemetic 'post-Fujii'.
Kranke P
Anaesthesia; 2012 Oct; 67(10):1063-7. PubMed ID: 22897144
[No Abstract] [Full Text] [Related]
32. Basics of designing a clinical trial: part II.
Whitney JD
J Wound Ostomy Continence Nurs; 2000 Nov; 27(6):293-5. PubMed ID: 11096408
[No Abstract] [Full Text] [Related]
33. The design and conduct of clinical trials to limit missing data.
Little RJ; Cohen ML; Dickersin K; Emerson SS; Farrar JT; Neaton JD; Shih W; Siegel JP; Stern H
Stat Med; 2012 Dec; 31(28):3433-43. PubMed ID: 22829439
[TBL] [Abstract][Full Text] [Related]
34. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
Pincus T
Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
[No Abstract] [Full Text] [Related]
35. Review of randomized controlled trials: issues to consider when designing a trial.
Pandis N
Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
[No Abstract] [Full Text] [Related]
36. Noninferiority drug trials fail to report adequate methodological detail: an assessment of noninferiority trials from 2010 to 2015.
Hong J; Tung A; Kinkade A; Tejani AM
J Clin Epidemiol; 2019 Apr; 108():144-146. PubMed ID: 30529004
[No Abstract] [Full Text] [Related]
37. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
Trafimow D; Rice S
Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
[No Abstract] [Full Text] [Related]
38. Yes, size does matter!: Sample size calculations for randomised trials.
Middleton L
BJOG; 2020 Jul; 127(8):1016-1017. PubMed ID: 31910329
[No Abstract] [Full Text] [Related]
39. Reporting studies of diagnostic accuracy: the STARD initiative.
Jones R
Fam Pract; 2004 Feb; 21(1):3. PubMed ID: 14760035
[No Abstract] [Full Text] [Related]
40. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
Moerbeek M
Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
